Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine

Molecules. 2023 Aug 8;28(16):5955. doi: 10.3390/molecules28165955.

Abstract

As a therapeutic tool inherited for thousands of years, traditional Chinese medicine (TCM) exhibits superiority in tumor therapy. The antitumor active components of TCM not only have multi-target treatment modes but can also synergistically interfere with tumor growth compared to traditional chemotherapeutics. However, most antitumor active components of TCM have the characteristics of poor solubility, high toxicity, and side effects, which are often limited in clinical application. In recent years, delivering the antitumor active components of TCM by nanosystems has been a promising field. The advantages of nano-delivery systems include improved water solubility, targeting efficiency, enhanced stability in vivo, and controlled release drugs, which can achieve higher drug-delivery efficiency and bioavailability. According to the method of drug loading on nanocarriers, nano-delivery systems can be categorized into two types, including physically encapsulated nanoplatforms and chemically coupled drug-delivery platforms. In this review, two nano-delivery approaches are considered, namely physical encapsulation and chemical coupling, both commonly used to deliver antitumor active components of TCM, and we summarized the advantages and limitations of different types of nano-delivery systems. Meanwhile, the clinical applications and potential toxicity of nano-delivery systems and the future development and challenges of these nano-delivery systems are also discussed, aiming to lay the foundation for the development and practical application of nano-delivery systems of TCM in clinical settings.

Keywords: antitumor active ingredients; chemical coupling; nano-delivery systems; pharmacological efficacy; physical encapsulation; traditional Chinese medicine.

Publication types

  • Review

MeSH terms

  • Biological Availability
  • Drug Delivery Systems
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Medicine, Chinese Traditional*
  • Nanoparticle Drug Delivery System

Substances

  • Nanoparticle Drug Delivery System

Grants and funding

This research received no external funding.